The NMR-derived conformation of neuropeptide AF, an orphan G-protein coupled receptor peptide

被引:14
|
作者
Miskolzie, M [1 ]
Kotovych, G [1 ]
机构
[1] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada
关键词
orphan G-protein coupled receptor peptide; peptide; NMR; conformation; neuropeptide AF; sodium dodecylsulfate-d(25); helix; neuropeptide; 5-doxyl-stearic acid; spin label;
D O I
10.1002/bip.10359
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The tertiary structure of the pain modulating and anti-opiate neuropeptide, human neuropeptide AF (NPAF) (the sequence is AGEGLNSQFWSLAAPQRF-NH2), was determined by H-1-NMR. The structure of NPAF was determined in two solvent systems, namely 50%/50% trifluoroethanol-d(3)/H2O (TFE/H2O) and in the cell membrane mimetic micelle, sodium dodecylsulfate-d(25) (SDS). The receptor for NPAF is an orphan G-protein coupled receptor, and the micellar 'SDS' solvent system was used to emulate the cell membrane surface in line with the Cell Membrane Compartments Theory proposed by R. Schwyzer (Biopolymers, 1995, Vol. 37, pp. 5-16). In both solvent systems, NPAF was found to be primarily alpha-helical within the central portion of the molecule, from Asn(6) to Ala(14). The N-terminus was random in both solvent systems. In the SDS solution, the C-terminal tetrapeptide was structured and formed a type I beta-turn, whereas in TFE/H2O it was unstructured, showing the importance of the C-terminal tetrapeptide in receptor recognition. NPAF was found to associate with SDS, and was shown to be near the surface of the micelle by spin label studies with 5-doxyl-stearic acid. (C) 2003 Wiley Periodicals, Inc.
引用
收藏
页码:201 / 215
页数:15
相关论文
共 50 条
  • [31] Orphan peptide and G protein-coupled receptor signalling in alcohol use disorder
    Anversa, Roberta Goncalves
    Maddern, Xavier J.
    Lawrence, Andrew J.
    Walker, Leigh C.
    BRITISH JOURNAL OF PHARMACOLOGY, 2024, 181 (05) : 595 - 609
  • [32] INHIBITION OF THROMBIN RECEPTOR SIGNALING BY A G-PROTEIN COUPLED RECEPTOR KINASE - FUNCTIONAL SPECIFICITY AMONG G-PROTEIN COUPLED RECEPTOR KINASES
    ISHII, K
    CHEN, J
    ISHII, M
    KOCH, WJ
    FREEDMAN, NJ
    LEFKOWITZ, RJ
    COUGHLIN, SR
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (02) : 1125 - 1130
  • [33] Latchkey mechanism for G-protein coupled receptor
    Arimoto, R
    Ragno, R
    Kisselev, OG
    Makara, GM
    Marshall, GR
    BIOPHYSICAL JOURNAL, 2000, 78 (01) : 42A - 42A
  • [34] ARRESTING G-PROTEIN COUPLED RECEPTOR ACTIVITY
    WILSON, CJ
    APPLEBURY, ML
    CURRENT BIOLOGY, 1993, 3 (10) : 683 - 686
  • [35] Halothane binding in a G-protein coupled receptor
    Ishizawa, Y
    Sharp, R
    Liebman, PA
    Eckenhoff, RG
    ANESTHESIOLOGY, 1999, 91 (3A) : U222 - U222
  • [36] G-PROTEIN ANTAGONISTS - A NOVEL HYDROPHOBIC PEPTIDE COMPETES WITH RECEPTOR FOR G-PROTEIN BINDING
    MUKAI, H
    MUNEKATA, E
    HIGASHIJIMA, T
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1992, 267 (23) : 16237 - 16243
  • [37] Biosensing with G-protein coupled receptor systems
    Lundstrom, I
    Svensson, S
    BIOSENSORS & BIOELECTRONICS, 1998, 13 (06): : 689 - 695
  • [38] A G-Protein Coupled Receptor and Macular Degeneration
    Figueroa, Anna G.
    McKay, Brian S.
    CELLS, 2020, 9 (04)
  • [39] G-protein - Coupled receptor drug screening
    Schneider, I
    GENETIC ENGINEERING NEWS, 2004, 24 (09): : 28 - 28
  • [40] Mechanism of G-Protein Coupled Receptor Activation
    Weis, William
    BIOPHYSICAL JOURNAL, 2011, 100 (03) : 363 - 363